TY  - GEN
AU  - Latus,Joerg
AU  - Klein,Reinhild
AU  - Koetter,Ina
AU  - Schwab,Matthias
AU  - Fritz,Peter
AU  - Kimmel,Martin
AU  - Alscher,M Dominik
AU  - Braun,Niko
TI  - Cholestatic liver disease after rituximab and adalimumab and the possible role of cross-reacting antibodies to Fab 2 fragments
SN  - 1932-6203
PY  - 2014///0818
KW  - Acute Disease
KW  - Adalimumab
KW  - Adult
KW  - Aged
KW  - Animals
KW  - Anti-Inflammatory Agents
KW  - administration & dosage
KW  - Antibodies, Antineutrophil Cytoplasmic
KW  - blood
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Cholestasis, Intrahepatic
KW  - Cross Reactions
KW  - Female
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - immunology
KW  - Immunologic Factors
KW  - Male
KW  - Mice
KW  - Middle Aged
KW  - Rituximab
KW  - Vasculitis, Central Nervous System
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1371/journal.pone.0078856
ER  -